Exhibit
31.1
CERTIFICATION
I,
Chandler D. Robinson, certify that:
1.
I have reviewed this Quarterly Report on Form
10-Q of Monopar Therapeutics Inc.;
2.
Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make
the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the
period covered by this report;
3.
Based on my knowledge, the financial statements, and
other financial information included in this report, fairly present
in all material respects
the financial condition, results of operations and cash flows of
the registrant as of, and for, the periods presented in this
report;
4.
The registrant's other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls
and procedures (as
defined in Exchange Act Rules 13a- 15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
(a) Designed such
disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in
which this report is being prepared;
(b) Designed such
internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally
accepted accounting principles;
(c) Evaluated the
effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation;
and
(d) Disclosed in
this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in
the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant's internal
control over financial reporting; and
5. The
registrant's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over
financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons
performing the equivalent functions):
(a) All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information;
and
(b) Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
control over financial reporting.
Date:
November 12, 2019
/s/ Chandler D. Robinson
Chandler D.
Robinson
Chief
Executive Officer